President & CEO
Impact Therapeutics, Inc.
Dr. Jun Bao, President & CEO, with more than 20 years of comprehensive experience in the production and research, extensive experience in drug research and development, technology transfer, licensing and business development, venture investment, entrepreneurship and corporate finance. Before IMPACT Therapeutics, he was SVP & CBO at Shenogen Pharma. He also worked as Director of corporate development and financial planning in Onyx followed by Director of Worldwide BD & Head of China BD in GSK. Moreover, in Seattle, he worked at ICOS Corporation and Cell Therapeutics as a business development executive with progressive responsibilities. Dr. Bao has MBA degree from Univ. of Chicago, PhD degree from Univ. of Kansas and postdoc training at Johns Hopkins School of Medicine. He also served Director of Board of BayHelix.